|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.38% |
|
+3.49% | +17.62% |
| 10/06 | Morgan Stanley Downgrades Hess Midstream to Underweight From Equal Weight, $38 Price Target | MT |
| 10/06 | Analyst recommendations: Nike, Pfizer, Hewlett Packard, Intel, The Trade Desk… |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 13.25 | 13.98 | 13.84 | 14.47 | 14.76 | |||||
Return on Total Capital | 13.87 | 14.69 | 14.61 | 15.29 | 15.47 | |||||
Return On Equity % | 59.43 | 96.81 | 136.22 | 159.08 | 151.59 | |||||
Return on Common Equity | 28.2 | 37.36 | 40.53 | 51.23 | 64.22 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 76.05 | 78.07 | 76.79 | 76.78 | 77.14 | |||||
SG&A Margin | 1.89 | 1.81 | 1.94 | 1.75 | 1.76 | |||||
EBITDA Margin % | 74.17 | 76.26 | 74.85 | 75.03 | 75.38 | |||||
EBITA Margin % | 60.41 | 62.05 | 60.57 | 61.45 | 62.18 | |||||
EBIT Margin % | 60.41 | 62.05 | 60.57 | 61.45 | 62.18 | |||||
Income From Continuing Operations Margin % | 51.32 | 48.67 | 45.06 | 44.07 | 42.23 | |||||
Net Income Margin % | 3.85 | 6.58 | 8.79 | 14.92 | 21.77 | |||||
Net Avail. For Common Margin % | 3.85 | 6.58 | 8.79 | 14.92 | 21.77 | |||||
Normalized Net Income Margin | -14.63 | -10.37 | -6.35 | 1.39 | 10.32 | |||||
Levered Free Cash Flow Margin | 33.52 | 28.43 | 30.87 | 22.86 | 25.27 | |||||
Unlevered Free Cash Flow Margin | 38.39 | 35.05 | 38.54 | 30.66 | 33.1 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.35 | 0.36 | 0.37 | 0.38 | 0.38 | |||||
Fixed Assets Turnover | 0.39 | 0.4 | 0.42 | 0.46 | 0.48 | |||||
Receivables Turnover (Average Receivables) | 11.28 | 10.47 | 10.88 | 11.33 | 11.19 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.78 | 0.83 | 0.65 | 0.68 | 0.85 | |||||
Quick Ratio | 0.72 | 0.79 | 0.62 | 0.65 | 0.81 | |||||
Operating Cash Flow to Current Liabilities | 4.65 | 5.4 | 4.12 | 4.29 | 5.24 | |||||
Days Sales Outstanding (Average Receivables) | 32.37 | 34.87 | 33.54 | 32.3 | 32.62 | |||||
Average Days Payable Outstanding | 36.02 | 40.4 | 83.03 | 89.1 | 69.53 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 340.39 | 545.48 | 884.2 | 746.16 | 861.38 | |||||
Total Debt / Total Capital | 77.29 | 84.51 | 89.84 | 88.18 | 89.6 | |||||
LT Debt/Equity | 337.74 | 545.01 | 880.75 | 741.33 | 853.96 | |||||
Long-Term Debt / Total Capital | 76.69 | 84.43 | 89.49 | 87.61 | 88.83 | |||||
Total Liabilities / Total Assets | 78.39 | 85.26 | 90.42 | 88.79 | 90.02 | |||||
EBIT / Interest Expense | 6.9 | 5.3 | 4.56 | 4.55 | 4.47 | |||||
EBITDA / Interest Expense | 8.47 | 6.51 | 5.64 | 5.55 | 5.42 | |||||
(EBITDA - Capex) / Interest Expense | 6.92 | 4.92 | 4.39 | 4.04 | 4.28 | |||||
Total Debt / EBITDA | 2.87 | 2.97 | 3.18 | 3.09 | 3.09 | |||||
Net Debt / EBITDA | 2.87 | 2.96 | 3.18 | 3.09 | 3.08 | |||||
Total Debt / (EBITDA - Capex) | 3.51 | 3.93 | 4.09 | 4.25 | 3.9 | |||||
Net Debt / (EBITDA - Capex) | 3.51 | 3.93 | 4.08 | 4.25 | 3.9 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 10.25 | 5.93 | 5.76 | 10.89 | 8.41 | |||||
Gross Profit, 1 Yr. Growth % | 21.34 | 8.75 | 4.02 | 10.87 | 8.93 | |||||
EBITDA, 1 Yr. Growth % | 21.73 | 8.93 | 3.79 | 11.16 | 8.92 | |||||
EBITA, 1 Yr. Growth % | 26.14 | 8.8 | 3.25 | 12.5 | 9.7 | |||||
EBIT, 1 Yr. Growth % | 26.14 | 8.8 | 3.25 | 12.5 | 9.7 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 27.41 | 0.45 | -2.08 | 8.44 | 3.88 | |||||
Net Income, 1 Yr. Growth % | 93.33 | 80.82 | 41.36 | 88.11 | 58.18 | |||||
Normalized Net Income, 1 Yr. Growth % | 14.88 | -24.95 | -35.25 | -124.36 | 702.4 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 34.35 | 14.2 | 3.48 | 19.71 | 14.86 | |||||
Accounts Receivable, 1 Yr. Growth % | 29.08 | 2.24 | 1.14 | 11.66 | 8.14 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.44 | 1.53 | 1.78 | 2.98 | 1.34 | |||||
Total Assets, 1 Yr. Growth % | 3.29 | 2.94 | 5.61 | 9.54 | 5.72 | |||||
Tangible Book Value, 1 Yr. Growth % | 63.28 | 20.09 | 38.8 | 56 | 7.08 | |||||
Common Equity, 1 Yr. Growth % | 63.28 | 20.09 | 38.8 | 56 | 7.08 | |||||
Cash From Operations, 1 Yr. Growth % | 23.97 | 8.25 | 0.62 | 8.53 | 4.63 | |||||
Capital Expenditures, 1 Yr. Growth % | -45.8 | 45.96 | -6.17 | 36.96 | -16.5 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 313.34 | -10.17 | 14.84 | -17.89 | 19.88 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 207.43 | -3.27 | 16.28 | -11.77 | 17.03 | |||||
Dividend Per Share, 1 Yr. Growth % | 12.97 | 12.78 | 8.97 | 10.96 | 9.63 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 19.12 | 8.07 | 5.84 | 8.29 | 9.65 | |||||
Gross Profit, 2 Yr. CAGR % | 26.57 | 14.87 | 6.36 | 7.39 | 9.9 | |||||
EBITDA, 2 Yr. CAGR % | 27.96 | 15.15 | 6.33 | 7.42 | 10.04 | |||||
EBITA, 2 Yr. CAGR % | 34.36 | 17.15 | 5.99 | 7.77 | 11.09 | |||||
EBIT, 2 Yr. CAGR % | 34.36 | 17.15 | 5.99 | 7.77 | 11.09 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 28.75 | 13.13 | -0.82 | 3.05 | 6.14 | |||||
Net Income, 2 Yr. CAGR % | -16.59 | 86.97 | 59.88 | 63.07 | 72.5 | |||||
Normalized Net Income, 2 Yr. CAGR % | 39.03 | -7.15 | -30.29 | -60.29 | 39.8 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -31.08 | 23.87 | 8.71 | 11.3 | 17.26 | |||||
Accounts Receivable, 2 Yr. CAGR % | 17.19 | 14.88 | 1.69 | 6.27 | 9.88 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.89 | 0.98 | 1.65 | 2.38 | 2.15 | |||||
Total Assets, 2 Yr. CAGR % | 3.12 | 3.12 | 4.27 | 7.56 | 7.61 | |||||
Tangible Book Value, 2 Yr. CAGR % | 24.58 | 40.03 | 29.11 | 47.15 | 29.25 | |||||
Common Equity, 2 Yr. CAGR % | 24.58 | 40.03 | 29.11 | 47.15 | 29.25 | |||||
Cash From Operations, 2 Yr. CAGR % | 30 | 15.84 | 4.36 | 4.5 | 6.56 | |||||
Capital Expenditures, 2 Yr. CAGR % | -35.77 | -11.06 | 17.02 | 13.36 | 6.94 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 723.52 | 92.69 | 1.57 | -2.9 | -0.79 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 306.61 | 72.45 | 6.06 | 1.29 | 1.61 | |||||
Dividend Per Share, 2 Yr. CAGR % | 115.85 | 12.87 | 10.86 | 9.96 | 10.29 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 19.09 | 14.55 | 7.29 | 7.5 | 8.33 | |||||
Gross Profit, 3 Yr. CAGR % | 20.81 | 20.33 | 11.13 | 7.84 | 7.9 | |||||
EBITDA, 3 Yr. CAGR % | 20.91 | 21.27 | 11.23 | 7.92 | 7.92 | |||||
EBITA, 3 Yr. CAGR % | 24.35 | 25.24 | 12.32 | 8.12 | 8.41 | |||||
EBIT, 3 Yr. CAGR % | 24.35 | 25.24 | 12.32 | 8.12 | 8.41 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 18.39 | 18.53 | 7.82 | 2.18 | 3.33 | |||||
Net Income, 3 Yr. CAGR % | -12.43 | 7.95 | 70.33 | 68.78 | 61.42 | |||||
Normalized Net Income, 3 Yr. CAGR % | 20.72 | 13.2 | -17.66 | -50.9 | 8.17 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 11.69 | -18.45 | 16.66 | 12.26 | 12.48 | |||||
Accounts Receivable, 3 Yr. CAGR % | 21.36 | 11.98 | 10.1 | 4.91 | 6.89 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.54 | 1.77 | 1.25 | 2.09 | 2.03 | |||||
Total Assets, 3 Yr. CAGR % | 5.23 | 3.06 | 3.94 | 6 | 6.94 | |||||
Tangible Book Value, 3 Yr. CAGR % | -15.05 | 23.07 | 39.62 | 37.51 | 32.36 | |||||
Common Equity, 3 Yr. CAGR % | -15.05 | 23.07 | 39.62 | 37.51 | 32.36 | |||||
Cash From Operations, 3 Yr. CAGR % | 19.44 | 22.3 | 10.53 | 5.73 | 4.54 | |||||
Capital Expenditures, 3 Yr. CAGR % | -12.29 | -15.56 | -9.46 | 23.32 | 2.38 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 42.5 | 293.48 | 62.16 | -5.38 | 4.17 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 40.17 | 151.95 | 51.22 | -0.25 | 6.28 | |||||
Dividend Per Share, 3 Yr. CAGR % | 12.16 | 73.85 | 11.56 | 10.89 | 9.85 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 18.75 | 17.09 | 13.6 | 12.01 | 8.23 | |||||
Gross Profit, 5 Yr. CAGR % | 23.68 | 20.4 | 14.81 | 14.97 | 10.64 | |||||
EBITDA, 5 Yr. CAGR % | 23.88 | 20.7 | 14.85 | 15.53 | 10.75 | |||||
EBITA, 5 Yr. CAGR % | 28.66 | 24.63 | 16.65 | 17.94 | 11.83 | |||||
EBIT, 5 Yr. CAGR % | 28.66 | 24.63 | 16.65 | 17.94 | 11.83 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 24.7 | 23.43 | 10.3 | 12.07 | 7.14 | |||||
Net Income, 5 Yr. CAGR % | -25.7 | 15.74 | 11.41 | 27.31 | 71.19 | |||||
Normalized Net Income, 5 Yr. CAGR % | 6.58 | 36.51 | -3.09 | -25.55 | 1.76 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | 21.76 | 10.49 | -7.64 | 16.9 | |||||
Accounts Receivable, 5 Yr. CAGR % | 21.95 | 16.02 | 13.07 | 9.66 | 10.01 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.41 | 4.71 | 3.38 | 2.01 | 1.61 | |||||
Total Assets, 5 Yr. CAGR % | 6.25 | 6.37 | 4.84 | 4.84 | 5.39 | |||||
Tangible Book Value, 5 Yr. CAGR % | -38.06 | -13.5 | 0.43 | 32.19 | 35.37 | |||||
Common Equity, 5 Yr. CAGR % | -38.06 | -13.5 | 0.43 | 32.19 | 35.37 | |||||
Cash From Operations, 5 Yr. CAGR % | 15.48 | 20.67 | 13.16 | 14.84 | 8.92 | |||||
Capital Expenditures, 5 Yr. CAGR % | -9.14 | 10.56 | -1.57 | -5 | -3.22 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 50.38 | 19.33 | 24.45 | 124.83 | 33.23 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 54.65 | 26.6 | 25.38 | 74.99 | 28.99 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | 19.9 | 11.64 | 44.74 | 11.05 |
- Stock Market
- Stocks
- HESM Stock
- Financials Hess Midstream LP
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















